| Study |
Outcome |
Control (n/N) |
Experimental (n/N) |
Absolute risk difference (95% CI) |
Standard median effect size |
| Pre |
Post |
Pre |
Post |
| Jousimaa 2002 |
Proportion of consultation decision compliant with guidelines (laboratory examinations) |
NA |
1372/1529 |
NA |
1481/1640 |
0.01 (‐0.02 to 0.03) |
‐0.02 |
| Proportion of consultation decision compliant with guidelines (radiological examinations) |
NA |
1416/1518 |
NA |
1504/1604 |
0 (‐0.01 to 0.02) |
| Proportion of consultation decision compliant with guidelines (physical examinations) |
NA |
1461/1545 |
NA |
1494/1610 |
‐0.02 (‐0.03 to ‐0.00) |
| Proportion of consultation decision compliant with guidelines (other examinations) |
NA |
248/307 |
NA |
235/314 |
‐0.06 (‐0.12 to 0.01) |
| Proportion of consultation decision compliant with guidelines (procedures) |
NA |
140/171 |
NA |
152/196 |
‐0.04 (‐0.13 to 0.04) |
| Proportion of consultation decision compliant with guidelines (physiotherapy) |
NA |
83/103 |
NA |
77/98 |
‐0.02 (‐0.13 to 0.09) |
| Proportion of consultation decision compliant with guidelines (non‐pharmacological treatments) |
NA |
110/122 |
NA |
80/92 |
‐0.03 (‐0.12 to 0.05) |
| Proportion of consultation decision compliant with guidelines (pharmacological treatment) |
NA |
1350/1568 |
NA |
1391/1654 |
‐0.02 (‐0.04 to 0.00) |
| Proportion of consultation decision compliant with guidelines (referrals) |
NA |
1508/1578 |
NA |
1619/1684 |
0.01 (‐0.01 to 0.02) |
